GlobeNewswire
Abstract: - Global Vitamin D Therapy Market to Reach $4. 2 Billion by 2027. - Amid the COVID-19 crisis, the global market for Vitamin D Therapy estimated at US$2. 1 Billion in the year 2020, is projected to reach a revised size of US$4.New York, April 13, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Vitamin D Therapy Industry" - https://www.reportlinker.com/p06033260/?utm_source=GNW 2 Billion by 2027, growing at aCAGR of 10.8% over the period 2020-2027. Oral, one of the segments analyzed in the report, is projected to record 11.1% CAGR and reach US$2.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Parenteral segment is readjusted to a revised 10.1% CAGR for the next 7-year period. - The U.S. Market is Estimated at $610.2 Million, While China is Forecast to Grow at 10.4% CAGR - The Vitamin D Therapy market in the U.S. is estimated at US$610.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$743.7 Million by the year 2027 trailing a CAGR of 10.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.5% and 9.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR. - Select Competitors (Total 36 Featured) - AbbottAlkem Laboratories Ltd.Cadila Healthcare Ltd.GlaxoSmithKline PLCMerck & Co., Inc.Novartis AGPfizer IncSanofiSun Pharmaceutical Industries Ltd.Torrent Pharmaceuticals Ltd. Read the full report: https://www.reportlinker.com/p06033260/?utm_source=GNW I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Vitamin D Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 2: World Historic Review for Vitamin D Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 3: World 15-Year Perspective for Vitamin D Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 Table 4: World Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 5: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 6: World 15-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 7: World Current & Future Analysis for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 8: World Historic Review for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 9: World 15-Year Perspective for Parenteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 10: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 11: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 12: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 13: World Current & Future Analysis for Osteoporosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 14: World Historic Review for Osteoporosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 15: World 15-Year Perspective for Osteoporosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 16: World Current & Future Analysis for Rickets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 17: World Historic Review for Rickets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 18: World 15-Year Perspective for Rickets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 19: World Current & Future Analysis for Muscle Weakness by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 20: World Historic Review for Muscle Weakness by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 21: World 15-Year Perspective for Muscle Weakness by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 22: World Current & Future Analysis for Autoimmune Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 23: World Historic Review for Autoimmune Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 24: World 15-Year Perspective for Autoimmune Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 25: World Current & Future Analysis for Skin Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 26: World Historic Review for Skin Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 27: World 15-Year Perspective for Skin Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 28: World Current & Future Analysis for Prescription Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 29: World Historic Review for Prescription Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 30: World 15-Year Perspective for Prescription Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 31: World Current & Future Analysis for OTC Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 32: World Historic Review for OTC Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 33: World 15-Year Perspective for OTC Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 III. MARKET ANALYSIS UNITED STATES Table 34: USA Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 35: USA Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 36: USA 15-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2012, 2020 & 2027 Table 37: USA Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 38: USA Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 39: USA 15-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 & 2027 Table 40: USA Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 41: USA Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 42: USA 15-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2012, 2020 & 2027 CANADA Table 43: Canada Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 44: Canada Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 45: Canada 15-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2012, 2020 & 2027 Table 46: Canada Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 47: Canada Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 48: Canada 15-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 & 2027 Table 49: Canada Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 50: Canada Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 51: Canada 15-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2012, 2020 & 2027 JAPAN Table 52: Japan Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 53: Japan Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 54: Japan 15-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2012, 2020 & 2027 Table 55: Japan Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 56: Japan Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 57: Japan 15-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 & 2027 Table 58: Japan Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 59: Japan Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 60: Japan 15-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2012, 2020 & 2027 CHINA Table 61: China Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 62: China Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 63: China 15-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2012, 2020 & 2027 Table 64: China Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 65: China Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 66: China 15-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 & 2027 Table 67: China Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 68: China Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 69: China 15-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2012, 2020 & 2027 EUROPE Table 70: Europe Current & Future Analysis for Vitamin D Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 71: Europe Historic Review for Vitamin D Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 72: Europe 15-Year Perspective for Vitamin D Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 Table 73: Europe Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 74: Europe Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 75: Europe 15-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2012, 2020 & 2027 Table 76: Europe Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 77: Europe Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 78: Europe 15-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 & 2027 Table 79: Europe Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 80: Europe Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 81: Europe 15-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2012, 2020 & 2027 FRANCE Table 82: France Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 83: France Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 84: France 15-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2012, 2020 & 2027 Table 85: France Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 86: France Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 87: France 15-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 & 2027 Table 88: France Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 89: France Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 90: France 15-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2012, 2020 & 2027 GERMANY Table 91: Germany Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 92: Germany Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 93: Germany 15-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2012, 2020 & 2027 Table 94: Germany Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 95: Germany Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 96: Germany 15-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 & 2027 Table 97: Germany Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 98: Germany Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 99: Germany 15-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2012, 2020 & 2027 ITALY Table 100: Italy Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 101: Italy Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 102: Italy 15-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2012, 2020 & 2027 Table 103: Italy Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 104: Italy Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 105: Italy 15-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 & 2027 Table 106: Italy Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 107: Italy Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 108: Italy 15-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2012, 2020 & 2027 UNITED KINGDOM Table 109: UK Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 110: UK Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 111: UK 15-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2012, 2020 & 2027 Table 112: UK Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 113: UK Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 114: UK 15-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 & 2027 Table 115: UK Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 116: UK Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 117: UK 15-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2012, 2020 & 2027 REST OF EUROPE Table 118: Rest of Europe Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 119: Rest of Europe Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 120: Rest of Europe 15-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2012, 2020 & 2027 Table 121: Rest of Europe Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 122: Rest of Europe Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 123: Rest of Europe 15-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 & 2027 Table 124: Rest of Europe Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 125: Rest of Europe Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 126: Rest of Europe 15-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2012, 2020 & 2027 ASIA-PACIFIC Table 127: Asia-Pacific Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 128: Asia-Pacific Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 129: Asia-Pacific 15-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2012, 2020 & 2027 Table 130: Asia-Pacific Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 131: Asia-Pacific Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 132: Asia-Pacific 15-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 & 2027 Table 133: Asia-Pacific Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 134: Asia-Pacific Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 135: Asia-Pacific 15-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2012, 2020 & 2027 REST OF WORLD Table 136: Rest of World Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 137: Rest of World Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 138: Rest of World 15-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2012, 2020 & 2027 Table 139: Rest of World Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Please contact our Customer Support Center to get the complete Table of ContentsRead the full report: https://www.reportlinker.com/p06033260/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001